| Description | Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia. |
| Synonyms | L0081, F-12511 |
| molecular weight | 469.72 |
| Molecular formula | C29H43NO2S |
| CAS | 202340-45-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 15 mg/mL (31.93 mM) |
| References | 1. Mesplet N, et al. Spectrofluorimetric study of eflucimibe-gamma-cyclodextrin inclusion complex. Eur J Pharm Biopharm. 2005;59(3):523-526. 2. Rodier E, et al. A three step supercritical process to improve the dissolution rate of eflucimibe. Eur J Pharm Sci. 2005;26(2):184-193. |